PLGA Nanoparticle-Based Formulations to Cross the Blood–Brain Barrier for Drug Delivery: From R&D to cGMP

The blood–brain barrier (BBB) is a natural obstacle for drug delivery into the human brain, hindering treatment of central nervous system (CNS) disorders such as acute ischemic stroke, brain tumors, and human immunodeficiency virus (HIV)-1-associated neurocognitive disorders. Poly(lactic-co-glycolic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceutics
Hlavní autoři: Zhi, Kaining, Raji, Babatunde, Nookala, Anantha R., Khan, Mohammad Moshahid, Nguyen, Xuyen H., Sakshi, Swarna, Pourmotabbed, Tayebeh, Yallapu, Murali M., Kochat, Harry, Tadrous, Erene, Pernell, Shelby, Kumar, Santosh
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8067506/
https://ncbi.nlm.nih.gov/pubmed/33917577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040500
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky